The use of an interleukin 1 receptor antagonist (anakinra) in the treatment of Schnitzler syndrome
Więcej
Ukryj
1
Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases, Military Institute of Medicine – National Research Institute, Warsaw, Poland
2
National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw, Poland
3
Department of Internal Medicine, Nephrology and Endocrinology with Laboratory of Nuclear Medicine, Clinical Provincial Hospital No. 2, Rzeszow, Poland
Data publikacji: 20-09-2024
Reumatologia 2024;62/4 (Suppl 1)(XXV KONGRES POLSKIEGO TOWARZYSTWA REUMATOLOGICZNEGO ):66
SŁOWA KLUCZOWE
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.